Sati H I, Ahya R, Watson H G
Department of Haematology, Aberdeen Royal Infirmary, and Aberdeen Blood Transfusion Centre, Aberdeen, UK.
Br J Haematol. 2001 May;113(2):556-7. doi: 10.1046/j.1365-2141.2001.02742.x.
In a formal study, we have identified increasing age, pretreatment renal impairment and diabetes mellitus as risk factors for the development of intravenous immunoglobulin-induced renal failure. Identification of these characteristics in potential recipients should alert clinicians to the associated increased risk of this serious complication.